TY - JOUR
T1 - Treatment of Intracerebral Vascular Malformations
T2 - When to Intervene
AU - Abbas, Rawad
AU - Al-Saiegh, Fadi
AU - Atallah, Elias
AU - Naamani, Kareem El
AU - Tjoumakaris, Stavropoula
AU - Gooch, Michael R.
AU - Herial, Nabeel A.
AU - Jabbour, Pascal
AU - Rosenwasser, Robert H.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose of review: This review highlights the complexity of intracranial vascular malformations and the importance of a multidisciplinary approach for management as it drastically changes from one patient to another and from one lesion to another. We talk about different types of malformations and different management strategies for each lesion. Recent findings: Brain arteriovenous malformations remain a challenging entity for neurosurgeons to this day. The ARUBA trial favored conservative and medical management over intervention, but it had many limitations and was met with criticism. Following diagnosis, brain AVMs are graded based on specific criteria and a risk–benefit assessment for treatment is done. Based on AVM and patient characteristics, either conservative management and observation (higher-grade AVMs) or intervention (lower-grade AVMs) is recommended. Treatment options available include microsurgical resection, endovascular embolization, stereotactic radiosurgery, or any combination of these. No two AVMs are managed the same way, and this review will discuss in detail the specifics for each strategy. We also discuss dural arteriovenous fistulas; they are managed like AVMs, but as opposed to AVMs, higher-grade lesions should be treated while lower-grade ones are observed. Summary: Brain AVMs or dural AVFs can lead to intracranial hemorrhage with catastrophic consequences. As such, many treatment strategies have been developed to help mitigate this risk. However, management is unique to every patient and lesion and thus, personalized, and tailored medicine is essential to achieve the best patient outcomes at the minimum risk possible.
AB - Purpose of review: This review highlights the complexity of intracranial vascular malformations and the importance of a multidisciplinary approach for management as it drastically changes from one patient to another and from one lesion to another. We talk about different types of malformations and different management strategies for each lesion. Recent findings: Brain arteriovenous malformations remain a challenging entity for neurosurgeons to this day. The ARUBA trial favored conservative and medical management over intervention, but it had many limitations and was met with criticism. Following diagnosis, brain AVMs are graded based on specific criteria and a risk–benefit assessment for treatment is done. Based on AVM and patient characteristics, either conservative management and observation (higher-grade AVMs) or intervention (lower-grade AVMs) is recommended. Treatment options available include microsurgical resection, endovascular embolization, stereotactic radiosurgery, or any combination of these. No two AVMs are managed the same way, and this review will discuss in detail the specifics for each strategy. We also discuss dural arteriovenous fistulas; they are managed like AVMs, but as opposed to AVMs, higher-grade lesions should be treated while lower-grade ones are observed. Summary: Brain AVMs or dural AVFs can lead to intracranial hemorrhage with catastrophic consequences. As such, many treatment strategies have been developed to help mitigate this risk. However, management is unique to every patient and lesion and thus, personalized, and tailored medicine is essential to achieve the best patient outcomes at the minimum risk possible.
KW - Arteriovenous fistula
KW - Arteriovenous malformation
KW - Endovascular
KW - Microsurgery
UR - http://www.scopus.com/inward/record.url?scp=85138172558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138172558&partnerID=8YFLogxK
U2 - 10.1007/s11940-022-00739-y
DO - 10.1007/s11940-022-00739-y
M3 - Review article
AN - SCOPUS:85138172558
SN - 1092-8480
VL - 24
SP - 655
EP - 671
JO - Current Treatment Options in Neurology
JF - Current Treatment Options in Neurology
IS - 12
ER -